Judgment of the General Court (Sixth Chamber) of 28 October 2020
Pharma Mar, SA v European Commission
Medicinal products for human use – Application for marketing authorisation for the medicinal product Aplidin – plitidepsin – Commission decision refusing authorisation – Regulation (EC) No 726/2004 – Scientific evaluation of the risks and benefits of a medicinal product – Committee for Medicinal Products for Human Use – Objective impartiality
Case T-594/18
Reports of Cases
published in the electronic Reports of Cases (Court Reports - general - 'Information on unpublished decisions' section)
Links to the texts
|
Curia |
EUR-Lex |
Autres Liens |
Judgment
ECLI:EU:T:2020:512 |
|
|
|